KDIGO Controversies Conference on the Management of Patients with Diabetes and Chronic Disease

February 5-8, 2015 Vancouver, Canada

--- CONFERENCE AGENDA ---

1

Thursday, February 5 19:00 – 21:00 hrs

19:00 hrs Welcome Reception & Informal Cocktails Location: Vistas 360

------

Friday, February 6 08:30 – 18:00 hrs

06:30 – 08:30 hrs Continental Breakfast Available Location: P2B Bistro

Introduction: Meeting Overview Location: Salon A

08:30 – 08:45 hrs Welcome & Introductions Presenters: John Davis, KDIGO CEO David Wheeler & Bert Kasiske, KDIGO Co-Chairs

08:45 – 09:15 hrs Conference Overview & Objectives Presenters: Per-Henrik Groop & Vlado Perkovic, Conference Co-Chairs

09:15 – 09:30 hrs of DKD Presenter: Per-Henrik Groop

Plenary Session #1

09:30 – 09:45 hrs What Can Be Achieved with Glycemic Control? Presenter: Michel Marre

09:45 – 10:00 hrs Balancing Risk and Benefit in Chronic Presenter: Merlin Thomas

10:00 – 10:15 hrs Safety of New Agents Presenter: Steven Kahn

10:15 – 11:00 hrs Q&A

2

11:00 – 11:15 hrs Break Location: Foyer

Plenary Session #2

11:15 – 11:45 hrs Novel Treatments in DKD Presenter: Rajiv Agarwal

11:45 – 12:15 hrs Experimental Agents in DKD Presenter: Robyn Langham

12:15 – 13:00 hrs Q&A

13:00 – 14:00 hrs Lunch Location: Salon F

Plenary Session #3

14:00 – 14:15 hrs Role of Antiplatelets in DKD Presenter: Meg Jardine

14:15 – 14:30 hrs Role of Novel Anticoagulants in DKD Presenter: Vlado Perkovic

14:30 – 15:00 hrs Dyslipidemia in DKD: Current & Future Lipid-Lowering Strategies Presenter: Christoph Wanner

15:00 – 15:45 hrs Q&A

15:45 – 16:00 hrs Break Location: Foyer

Plenary Session #4

16:00 – 16:15 hrs Lifestyle & Dietary Interventions in DKD Presenter: Meg Jardine

16:15 – 16:30 hrs Is Lower the BP Target the Better in DKD? Presenter: George Bakris

3

16:30 – 16:45 hrs Is Dual Blockade in DKD Dead? Presenter: Mark Cooper

16:45 – 17:00 hrs Role of Mineralocorticoid Receptor Antagonists in DKD Presenter: Peter Rossing

17:00 – 17:45 hrs Q&A

17:45 – 18:00 hrs Closing Remarks Presenter: Vlado Perkovic

18:00 hrs Adjourn (evening on own)

------

Saturday, February 7 08:30 to 18:15 hrs

06:30 – 08:30 hrs Continental Breakfast Available Location: P2B Bistro

Plenary Session #5

08:30 – 08:45 hrs Improving Future Designs Presenter: Dick de Zeeuw

08:45 – 09:00 hrs Moving from Efficacy to Effectiveness Presenter: Brenda Hemmelgarn

09:00 – 09:45 hrs Q&A

09:45 – 10:00 hrs Breakout Session Remit Presenters: Per-Henrik Groop & Vlado Perkovic

10:00 – 12:30 hrs Breakout Session 1 Breakout Group #1: Safety of Treatments in Diabetes and Kidney Disease Discussion Leaders: Brenda Hemmelgarn & Merlin Thomas Location: Salon E

4

Breakout Group #2: Efficacy of Glycemic Control Discussion Leaders: Mark Cooper & Steven Kahn Location: Salon D

Breakout Group #3: Therapies for Protecting Kidney Function Discussion Leaders: Rajiv Agarwal & Paola Fioretto Location: Salon A

Breakout Group #4: Therapeutic Effects on Cardiovascular Risk & Other Outcomes Discussion Leaders: Adeera Levin & Christoph Wanner Location: Salon C

12:30 – 13:30 hrs Lunch Location: Salon F

Breakout Group Preliminary Reports and Discussion Location: Salon A

13:30 – 14:00 hrs Breakout Group #1: Safety of Treatments in Diabetes and Kidney Disease Discussion Leaders: Brenda Hemmelgarn & Merlin Thomas

14:00 – 14:30 hrs Breakout Group #2: Efficacy of Glycemic Control Discussion Leaders: Mark Cooper & Steven Kahn

14:30 – 15:00 hrs Breakout Group #3: Therapies for Protecting Kidney Function Discussion Leaders: Rajiv Agarwal & Paola Fioretto

15:00 – 15:30 hrs Breakout Group #4: Therapeutic Effects on Cardiovascular Risk & Other Outcomes Discussion Leaders: Adeera Levin & Christoph Wanner

15:30 – 15:45 hrs Break Location: Foyer

15:45 – 18:15 hrs Breakout Session 2 Breakout Group #1: Safety of Treatments in Diabetes and Kidney Disease Discussion Leaders: Brenda Hemmelgarn & Merlin Thomas Location: Salon E

5

Breakout Group #2: Efficacy of Glycemic Control Discussion Leaders: Mark Cooper & Steven Kahn Location: Salon D

Breakout Group #3: Therapies for Protecting Kidney Function Discussion Leaders: Rajiv Agarwal & Paola Fioretto Location: Salon A

Breakout Group #4: Therapeutic Effects on Cardiovascular Risk & Other Outcomes Discussion Leaders: Adeera Levin & Christoph Wanner Location: Salon C

19:00 hrs Group Dinner Location: Black & Blue Restaurant (Meet in hotel lobby at 19:00 hrs to walk to restaurant)

------

Sunday, February 8 08:30 to 12:00 hrs

06:30 – 08:30 hrs Continental Breakfast Available Location: P2B Bistro

Breakout Group Final Reports and Discussion Location: Salon A

08:30 – 09:15 hrs Breakout Group #1: Safety of Treatments in Diabetes and Kidney Disease Discussion Leaders: Brenda Hemmelgarn & Merlin Thomas

09:15 – 10:00 hrs Breakout Group #2: Efficacy of Glycemic Control Discussion Leaders: Mark Cooper & Steven Kahn

10:00 – 10:45 hrs Breakout Group #3: Therapies for Protecting Kidney Function Discussion Leaders: Rajiv Agarwal & Paola Fioretto

6

10:45 – 11:30 hrs Breakout Group #4: Therapeutic Effects on Cardiovascular Risk & Other Outcomes Discussion Leaders: Adeera Levin & Christoph Wanner

11:30 – 12:00 hrs Conference summation and next steps

7